Despite myriad challenges, clinicians see room for progress.
Image credit: Shutterstock/David Tadevosian.
New Research In
Physical Sciences
Featured Portals
Articles by Topic
Biological Sciences
Featured Portals
Articles by Topic
-
Contributed by Robert Langer, March 3, 2006
-
↵ ‡O.C.F., J.C., and B.A.T. contributed equally to this work.
Abstract
Targeted uptake of therapeutic nanoparticles in a cell-, tissue-, or disease-specific manner represents a potentially powerful technology. Using prostate cancer as a model, we report docetaxel (Dtxl)-encapsulated nanoparticles formulated with biocompatible and biodegradable poly(d,l-lactic-co-glycolic acid)-block-poly(ethylene glycol) (PLGA-b-PEG) copolymer and surface functionalized with the A10 2′-fluoropyrimidine RNA aptamers that recognize the extracellular domain of the prostate-specific membrane antigen (PSMA), a well characterized antigen expressed on the surface of prostate cancer cells. These Dtxl-encapsulated nanoparticle-aptamer bioconjugates (Dtxl-NP-Apt) bind to the PSMA protein expressed on the surface of LNCaP prostate epithelial cells and get taken up by these cells resulting in significantly enhanced in vitro cellular toxicity as compared with nontargeted nanoparticles that lack the PSMA aptamer (Dtxl-NP) (P < 0.0004). The Dtxl-NP-Apt bioconjugates also exhibit remarkable efficacy and reduced toxicity as measured by mean body weight loss (BWL) in vivo [body weight loss of 7.7 ± 4% vs. 18 ± 5% for Dtxl-NP-Apt vs. Dtxl-NP at nadir, respectively (mean ± SD); n = 7]. After a single intratumoral injection of Dtxl-NP-Apt bioconjugates, complete tumor reduction was observed in five of seven LNCaP xenograft nude mice (initial tumor volume of ≈300 mm3), and 100% of these animals survived our 109-day study. In contrast, two of seven mice in the Dtxl-NP group had complete tumor reduction with 109-day survivability of only 57%. Dtxl alone had a survivability of only 14%. Saline and nanoparticles without drug were similarly nonefficacious. This report demonstrates the potential utility of nanoparticle-aptamer bioconjugates for a therapeutic application.
Footnotes
- §To whom correspondence may be addressed. E-mail: ofarokhzad{at}partners.org or rlanger{at}mit.edu
-
↵ ‖Present address: Department of Materials Science and Engineering, University of Illinois at Urbana–Champaign, 1304 West Green Street, Urbana, IL 61801.
-
Author contributions: O.C.F., J.C., B.A.T., I.S., S.J., P.W.K., J.P.R., and R.L. designed research, performed research, contributed new reagents/analytic tools, analyzed data, and wrote the paper.
-
Conflict of interest statement: No conflicts declared.
- Abbreviations:
- PCa,
- prostate cancer;
- Dtxl,
- docetaxel;
- NP,
- nanoparticle;
- Apt,
- aptamer;
- PLGA,
- poly(d,l-lactic-co-glycolic acid);
- PEG,
- poly(ethylene glycol);
- PSMA,
- prostate-specific membrane antigen;
- H&E,
- hematoxylin/eosin;
- BWL,
- body weight loss.
Abbreviations:
- © 2006 by The National Academy of Sciences of the USA
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Sign up for Article Alerts
Jump to section
You May Also be Interested in
Better explicating the strengths and shortcomings of these models will help refine projections and improve transparency in the years ahead.
Image credit: Witsawat.S.
Using CRISPR, researchers showed that a region some used to label “junk DNA” has a major role in a rare genetic disorder.
Image credit: Nathan Devery.
Mara Reed and Michael Manga explore why Yellowstone's Steamboat Geyser resumed erupting in 2018.
Some songbird parents might improve their own fitness by manipulating their offspring into leaving the nest early, at the cost of fledgling survival, a study finds.
Image credit: Gil Eckrich (photographer).